Dr. Lal PathLabs strengthens its genomics capabilities with Illumina's NovaSeq X Series

The NovaSeq X system features Illumina's cutting-edge XLEAP-SBS chemistry, offering unmatched throughput, accuracy, and sustainability

Illumina appoints Joydeep Goswami as Interim CFO

Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.

Illumina unveils pathbreaking genomic profiling test for cancer in Europe

The single in vitro diagnostic test helps inform therapy decisions according to clinical guidelines to enable precision medicine earlier in the disease journey

Illumina and Trivitron collaborate for next-generation sequencing in India

In numerous neurological and rare disorders, where clinical characteristics can be confusing, NGS-based approaches have demonstrated considerable increases in disease detection rates over other approaches

Illumina welcomes Carissa Rollins as Chief Information Officer

Most recently, Rollins was the Chief Information Officer at UnitedHealthcare

Illumina and Sequoia Capital China selects startups for Genomics

First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics

Illumina donates US $ I million in sequencing capabilities to BMC in Mumbai

It supports sequencing-based COVID 19 surveillance in India

Sun Pharma gets FDA approval for new device to treat skin disease

Syensqo partners with MezLight to launch the world’s first sterile reusable surgical task light

Novel illumination system with key components molded in Radel® PPSU for durability and repeated sterilization

AbbVie announces emotional impact report on mental health of underrepresented CLL cancer patients

CLL is one of the most common leukemias among adults affecting more than 200,000 people in the US